Immunosuppression Does Not Appear to Affect Echinococcal Cyst Viability as Confirmed by Immunoblotting Test: A Case Report in a Lung Transplant Patient
The American Journal of Tropical Medicine and Hygiene · 10.11.2026
DOI: 10.4269/ajtmh.26-0403 ↗Kurz gefasst
Fallbericht in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 10.11.2026. Verfasst von Raffaella Lissandrin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A 61-year-old Italian woman was diagnosed with a CE4 echinococcal cyst in the seventh hepatic segment. The cyst was managed conservatively (“watch and wait”) as per WHO guidelines. Serology for Echinococcus granulosus (ELISA) was negative. Five years later, in September 2025, the patient underwent bilateral lung transplant for chronic obstructive pulmonary disease. Induction with basiliximab, steroids, and treatment with tacrolimus and mycophenolic acid was started. Serology for E. granulosus (ELISA, rapid test [RT], and immunoblotting [IB]) remained negative, and the patient was managed expectantly. Serology with ELISA, RT, and IB remained negative at 0, 1, 3, and 6 months posttransplant. The cyst remained unchanged at all time points. Although anecdotal, this finding supports the hypothesis that unlike alveolar echinococcosis, immunosuppression has no effect on the viability of E. granulosus cysts. This has important clinical consequences. The American Society of Transplantation suggests treating patients for cystic echinococcosis before transplantation, and for adequate candidates, it recommends surgical removal with perioperative albendazole, an approach not supported by the literature. The need for treatment or surgical management of cystic echinococcosis in immunocompromised patients should be reconsidered.
Autor:innen und Institutionen
- Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- WHO Collaborating Centre for Clinical Management of Cystic Echinococcosis, University of Pavia, Pavia, Italy.
- Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Regional Centre for Infectious Diseases (CEREMI), Lombardy Region, Italy.
- Pulmonology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
Zitieren
APA
Lissandrin, R., Vola, A., Briganti, D. F., Frattola, S., Leka, A., Seminari, E., & Brunetti, E. (2026). Immunosuppression Does Not Appear to Affect Echinococcal Cyst Viability as Confirmed by Immunoblotting Test: A Case Report in a Lung Transplant Patient. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.26-0403
Vancouver
Lissandrin R, Vola A, Briganti DF, Frattola S, Leka A, Seminari E, et al. Immunosuppression Does Not Appear to Affect Echinococcal Cyst Viability as Confirmed by Immunoblotting Test: A Case Report in a Lung Transplant Patient. The American Journal of Tropical Medicine and Hygiene. 2026. doi:10.4269/ajtmh.26-0403
BibTeX
@article{Lissandrin2026,
author = {Lissandrin, Raffaella and Vola, Ambra and Briganti, Domenica Federica and Frattola, Sofia and Leka, Armanda and Seminari, Elena and Brunetti, Enrico},
title = {Immunosuppression Does Not Appear to Affect Echinococcal Cyst Viability as Confirmed by Immunoblotting Test: A Case Report in a Lung Transplant Patient},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
doi = {10.4269/ajtmh.26-0403}
}
EUVIMED